Ljubljana, SLOVENIA — Microincision cataract surgery with implantation of the Incise IOL from Bausch + Lomb showed good visual and anatomic outcomes in a preliminary 4- to 6-month report from a multicenter European study.
The Incise is a one-piece hydrophilic acrylic IOL that can be implanted with a dedicated 1.5-mm diameter injector through incisions of less than 2 mm.
“We implanted this lens in 25 eyes of 25 patients. The Stellaris system was used to perform microcoaxial MICS through a 1.8-mm incision. After implantation, incision measurements showed a mean stretching of 0.06 mm,” Antonio Toso, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.
At 4 to 6 months, distance vision was between 20/32 and 20/25 uncorrected and 20/20 with correction. Manifest refraction spherical equivalent was –0.28 D
“To determine IOL centration, the distance between the centers of the IOL optic edge and the pupil margin was calculated. All European sites sent slit lamp images to an independent observer at Plymouth University, U.K., where a specific software was used to measure centration. Our postoperative value was consistent with conventional one- or three-piece IOLs,” Toso said.
Long-term results will show the performance of the lens in relation to formation of posterior capsule opacification.
Disclosure: The study centers receive grant support from Bausch + Lomb for the study.